Please use this identifier to cite or link to this item:
https://dipositint.ub.edu/dspace/handle/2445/207946
Title: | Delphi initiative for early-onset colorectal cancer (DIRECt) international management guidelines |
Author: | Cavestro, Giulia Martina Mannucci, Alessandro Balaguer, Francesc Hampel, Heather Kupfer, Sonia S. Repici, Alessandro Sartore-Bianchi, Andrea Seppala, Toni T. Valentini, Vincenzo Boland, Clement Richard Brand, Randall E. Buffart, Tineke E. Burke, Carol A. Caccialanza, Riccardo Cannizzaro, Renato Cascinu, Stefano Cercek, Andrea Crosbie, Emma J. Danese, Silvio Dekker, Evelien Daca-Alvarez Maria Deni, Francesco Dominguez Valentin, Mev Eng, Cathy Goel, Ajay Guillem, Jose G. Houwen, Britt B. S. L. Kahi, Charles Kalady, Matthew F. Kastrinos, Fay Kuehn, Florian Laghi, Luigi Latchford, Andrew Liska, David Lynch, Patrick M. Malesci, Alberto Mauri, Giancarlo Meldolesi, Elisa Moller, Pal Monahan, Kevin Moeslein, Gabriela Murphy, Caitlin J. Nass, Karlijn Ng, Kimmie Oliani, Cristina Papaleo, Enrico Patel, Swati G. Puzzono, Marta Remo, Andrea Ricciardiello, Luigi Ripamonti, Carla Ida Siena, Salvatore Singh, Satish K. Stadler, Zsofia K. Stanich, Peter P. Syngal, Sapna Turi, Stefano Urso, Emanuele Damiano Valle, Laura Vanni, Valeria Stella Vilar, Eduardo Vitellaro, Marco You, Yi-Qian Nancy Yurgelun, Matthew B. Zuppardo, Raffaella Alessia Stoffel, Elena |
Keywords: | Diagnòstic Càncer colorectal Adults Diagnosis Colorectal cancer Adulthood |
Issue Date: | 20-Dec-2022 |
Publisher: | Elsevier |
Abstract: | Background & aims: Patients with early-onset colorectal cancer (eoCRC) are managed according to guidelines that are not age-specific. A multidisciplinary international group (DIRECt), composed of 69 experts, was convened to develop the first evidence-based consensus recommendations for eoCRC. Methods: After reviewing the published literature, a Delphi methodology was used to draft and respond to clinically relevant questions. Each statement underwent 3 rounds of voting and reached a consensus level of agreement of ≥80%. Results: The DIRECt group produced 31 statements in 7 areas of interest: diagnosis, risk factors, genetics, pathology-oncology, endoscopy, therapy, and supportive care. There was strong consensus that all individuals younger than 50 should undergo CRC risk stratification and prompt symptom assessment. All newly diagnosed eoCRC patients should receive germline genetic testing, ideally before surgery. On the basis of current evidence, endoscopic, surgical, and oncologic treatment of eoCRC should not differ from later-onset CRC, except for individuals with pathogenic or likely pathogenic germline variants. The evidence on chemotherapy is not sufficient to recommend changes to established therapeutic protocols. Fertility preservation and sexual health are important to address in eoCRC survivors. The DIRECt group highlighted areas with knowledge gaps that should be prioritized in future research efforts, including age at first screening for the general population, use of fecal immunochemical tests, chemotherapy, endoscopic therapy, and post-treatment surveillance for eoCRC patients. Conclusions: The DIRECt group produced the first consensus recommendations on eoCRC. All statements should be considered together with the accompanying comments and literature reviews. We highlighted areas where research should be prioritized. These guidelines represent a useful tool for clinicians caring for patients with eoCRC. |
Note: | Reproducció del document publicat a: https://doi.org/10.1016/j.cgh.2022.12.006 |
It is part of: | Clinical Gastroenterology and Hepatology, 2022, vol. 21, num.3, p. 581-637 |
URI: | https://hdl.handle.net/2445/207946 |
Related resource: | https://doi.org/10.1016/j.cgh.2022.12.006 |
ISSN: | 1542-3565 |
Appears in Collections: | Articles publicats en revistes (Medicina) Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
257049.pdf | 2.32 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License